Basaloid SCC
Overall, 28 patients were diagnosed with basaloid carcinoma, and while
the treatment modality was surgery in 25 patients, the remaining 3
patients were treated with primary RT or CRT. The information about the
treatment modalities of the primary disease, recurrence, and treatment
of recurrence is given in Table 3 .
During the follow-up, a second primary lung malignancy was detected in 3
patients all of whom were treated with surgery and CRT for larynx, and
all of them died due to the lung malignancy. One patient died during
primary CRT and one during adjuvant CRT due to accompanying medical
problems. One patient died for a reason not related to the disease.
Lastly, 5 patients died due to tumor recurrence. The remaining 17
patients were disease-free in their last follow-up.
The median follow-up duration is 57 months (8-141). 5-years
disease-specific and overall survival rates are 69.9% and 61.8%
respectively.